How to Detect Mold in Breast Implants

Detecting mold inside or around breast implants is difficult because there is no simple at-home test, and standard screening often misses fungal contamination entirely. The process typically requires a combination of imaging, fluid sampling, and specialized laboratory cultures, and in many cases fungi are only discovered when the implant is surgically removed. Published case reports suggest that fungal colonization of breast implants is probably more common than the medical literature reflects, in part because clinicians do not always think to look for it.

Why Fungal Contamination Goes Unrecognized

Breast implant infections are usually assumed to be bacterial. When a patient develops redness, swelling, or fluid buildup around an implant, the standard workup focuses on common bacteria like staphylococcus. Fungi grow more slowly than bacteria in the lab, require different culture media, and can produce symptoms that overlap almost completely with bacterial infection or even autoimmune-type reactions. A commentary in the journal Pathogens noted that filamentous fungal infections of breast implants remain underrecognized compared with bacterial and yeast infections, despite their potential to cause significant inflammation and to penetrate deeply into the tissue capsule that forms around every implant.¹ That deep penetration means the infection can persist even after antibiotic courses that would clear a typical bacterial problem.

Adding to the challenge, many fungal species that colonize implants are opportunistic environmental organisms rather than well-known pathogens. A case review published in PLOS ONE documented that, at the time of publication, only about 15 confirmed cases of breast implant fungal infections had been reported in the medical literature, involving species like Aspergillus, Candida, Curvularia, Paecilomyces, Penicillium, and Trichosporon.² Fifteen confirmed cases in the entire literature does not mean fungal contamination is vanishingly rare. It means the tools and clinical suspicion needed to find it are rarely applied.

Signs and Symptoms That Might Point to Mold

There is no symptom that uniquely screams “mold in the implant.” The signs overlap with bacterial infection, capsular contracture, and what many patients and clinicians call breast implant illness. That said, certain patterns raise the index of suspicion for fungal involvement:

Late-onset fluid collection: Swelling that develops months or years after surgery, rather than in the first few weeks, can indicate a slow-growing organism like a mold rather than a fast-acting bacterium.
Persistent or recurring infection: If antibiotics repeatedly fail to resolve an implant-related infection, a fungal cause should be considered. Antibiotics do not kill mold.
Unusual capsular changes: Hardening, thickening, or pain around the implant (capsular contracture) that develops gradually and does not respond to standard treatments can be driven by chronic fungal biofilm.
Discolored fluid: One documented case of Candida colonizing a tissue expander found that the internal fluid had turned a turbid brown color, which was discovered only when the device was accessed for a scheduled fill.³
Systemic complaints: Fatigue, joint pain, brain fog, and other whole-body symptoms that patients describe as breast implant illness may, in some cases, have a microbial component, though this link is still being studied.

One case that underscores the difficulty of early detection involved a patient with no known immune problems who developed significant infection with Scedosporium apiospermum at both breast augmentation sites.⁴ The patient was immunocompetent, meaning the infection could not be written off as a consequence of a weakened immune system. Cases like this suggest that healthy patients can harbor implant-related mold without realizing it until the infection becomes advanced enough to cause obvious symptoms.

What Imaging Can and Cannot Show

MRI is the best non-invasive tool for evaluating the space around a breast implant. It can detect fluid collections, masses, and signs of capsular rupture. However, imaging cannot tell you whether a fluid collection contains mold. What it can do is flag a peri-implant fluid collection that warrants further investigation. A study of over a thousand women with silicone implants found that about 1.7% had a peri-implant fluid collection or mass visible on MRI.⁵ Most of those turned out to be benign, but the study’s authors recommended that when a late peri-implant fluid collection is found, ultrasound-guided fine-needle aspiration should be performed to rule out lymphoma and, by extension, to characterize whatever is in the fluid.

Ultrasound is more accessible and less expensive than MRI. It can identify fluid pockets around implants and guide a needle for aspiration. But like MRI, it only tells you that something is there, not what it is. A fluid collection that looks identical on ultrasound could be sterile seroma, bacterial infection, fungal infection, or in rare cases something more serious. The value of imaging is as a trigger for the next step: getting a sample of the fluid out and into a lab.

Fluid Aspiration and Culture

The most direct way to detect mold while the implant is still in place is to aspirate peri-implant fluid and send it for microbiological culture. This is a needle-based procedure, usually guided by ultrasound, where fluid is drawn from the space around the implant and submitted to a laboratory. For fungal detection, the critical detail is that the lab must be specifically asked to culture for fungi. Standard wound cultures are optimized for bacteria and use media and incubation conditions that will not grow most molds.

Fungal culture requires different agar, different temperatures, and much longer incubation times. A study investigating biofilms in breast implant illness patients described their protocol: capsular tissue was ground, then cultured on Sabouraud agar at both body temperature and room temperature, with daily inspection for up to four weeks.⁶ Four weeks is a long time compared with the two or three days a bacterial culture needs. If your surgeon or lab does not specifically request fungal culture, the sample may come back “negative” even when mold is present. If you suspect fungal involvement, it is worth explicitly asking your doctor to order both bacterial and fungal cultures, including cultures for atypical organisms and acid-fast bacilli.

That same study found Candida in at least one patient in the breast implant illness group, along with polymicrobial growth in another patient.⁶ This is consistent with the broader pattern: when researchers actually look for fungi using appropriate methods, they sometimes find them.

PCR and Molecular Testing

Traditional culture has a significant blind spot. Some organisms are viable and causing problems but do not grow well in the lab. Others may be embedded in biofilm on the implant capsule, making them hard to recover by simple aspiration. Molecular testing, particularly polymerase chain reaction (PCR), bypasses these limitations by detecting the DNA of organisms directly, without needing to grow them first.

PCR-based capsule testing has shown that it can identify fungal DNA in implant capsules where standard pathology found nothing.⁷ When fungal DNA is found, clinicians can add antifungal treatment and dietary modifications aimed at reducing fungal proliferation. This approach is still relatively new and not yet part of routine practice. Most plastic surgeons do not order PCR testing on explanted capsular tissue, and insurance coverage for it varies. But for patients who have unexplained symptoms after implant removal or who want the most thorough evaluation possible, PCR testing of capsular tissue can catch what cultures miss.

The practical limitation is that PCR testing typically requires tissue, not just fluid. That means it is most useful at the time of explant surgery, when the capsule is already being removed. It is less useful as a screening tool for patients who still have their implants in place and are trying to figure out whether mold is present without undergoing surgery.

What Surgeons Find During Explant

For many patients, the actual discovery of mold happens in the operating room. When implants are removed along with their surrounding capsule (a procedure called en bloc capsulectomy), the surgeon can visually inspect the capsular tissue for signs of fungal growth. Sometimes this is obvious: discolored patches, unusual textures, or a foul smell that differs from the typical findings in a straightforward capsular contracture case. Other times the capsule looks unremarkable to the naked eye, and only laboratory analysis reveals fungal presence.

This is why many surgeons who specialize in explant now routinely send capsular tissue for both bacterial and fungal cultures, and increasingly for PCR analysis. The window of opportunity is the surgery itself. Once the tissue is discarded, the chance to identify mold is gone. If you are planning an explant and suspect microbial contamination, discussing a comprehensive culture protocol with your surgeon before the procedure is the single most useful step you can take.

Which Fungi Actually Grow in Breast Implants

The range of fungal species found in breast implant cases is surprisingly diverse. Candida species are the most commonly reported, which makes sense because Candida lives on human skin and mucous membranes and readily colonizes foreign materials in the body. But the list extends well beyond Candida. The PLOS ONE case review catalogued Aspergillus, Curvularia, Paecilomyces, Penicillium, and Trichosporon among the species identified in implant infections.² That study itself documented a case involving Quambalaria cyanescens, a species so unusual in human infection that the authors questioned whether it was a true pathogen or merely an environmental contaminant that happened to end up in the implant pocket.

That question, contaminant versus pathogen, comes up frequently in this field. Environmental molds like Aspergillus and Penicillium are everywhere: in soil, in air, in dust. Their spores can land in a surgical wound during the procedure itself, colonize the implant pocket during healing, or theoretically reach the implant through the bloodstream. The presence of mold DNA or even a positive culture does not always mean the mold is actively causing disease. It might be sitting quietly in a biofilm without triggering symptoms. But the distinction matters less than you might think. A biofilm of any organism on a foreign body can trigger chronic low-grade inflammation, and that inflammation can produce symptoms whether or not the organism is actively “infecting” in the traditional sense.

Filamentous fungi, the molds that grow in branching thread-like structures rather than the round budding cells of yeast like Candida, deserve special attention. A commentary on inflammatory pathology in breast implants emphasized that filamentous fungal biofilms can penetrate deeply into the capsular tissue surrounding the implant, a behavior that distinguishes them from bacterial and yeast biofilms and may explain why they cause a different pattern of inflammation.¹ This deep tissue penetration could also make them harder to eradicate without complete capsule removal.

Can Mold Penetrate the Implant Shell Itself

A reasonable worry is whether mold can grow through the silicone shell and contaminate the gel or saline inside the implant. Research on this question has produced a reassuring finding, at least for intact shells. A laboratory study testing whether Aspergillus fumigatus spores could penetrate silicone breast implant shells found that in none of the experimental conditions were the fungal spores or their thread-like hyphae able to get through the silicone material.⁸ This suggests that an intact, undamaged silicone shell acts as an effective physical barrier against fungal intrusion.

The key word there is “intact.” Implants can develop micro-tears, shell failure, or valve leaks over time. A ruptured saline implant that allows body fluid to enter and exit creates an entirely different environment from a sealed shell. The Candida colonization case mentioned earlier involved a tissue expander, which has a port that is accessed repeatedly with a needle for saline injection, creating potential entry points for skin flora to reach the interior.³ The authors of that case report emphasized that colonization of silicone implants by opportunistic fungi is probably more common than has been reported and recommended precautions to reduce the risk during any procedure that breaches the implant system.

So while an intact modern silicone gel implant is unlikely to have mold growing inside its shell, the space outside the shell, within the fibrous capsule, is a different story. That peri-implant pocket is warm, moist, and contains a foreign body, conditions that biofilm-forming organisms find hospitable.

Practical Steps If You Suspect Fungal Contamination

If you have breast implants and are experiencing symptoms that have not responded to standard treatments, or if you are concerned about mold for any reason, the detection pathway involves a few specific actions that are worth knowing about before you see your doctor.

Request imaging: An MRI or ultrasound can identify fluid collections around the implant. A fluid collection alone does not confirm mold, but it identifies a pocket that can be sampled.
Ask for fungal-specific cultures: If fluid is aspirated, explicitly request that it be cultured for fungi in addition to bacteria. This requires Sabouraud agar and extended incubation, up to four weeks, so a standard bacterial culture order will not cover it.
Discuss PCR testing at explant: If you are undergoing implant removal, ask your surgeon to send capsular tissue for PCR-based microbial analysis. This catches organisms that do not grow in culture.
Find a surgeon experienced with explant pathology: Surgeons who regularly perform en bloc capsulectomies are more likely to have established protocols for microbiological testing and to recognize intraoperative signs of fungal contamination.
Keep records: Document your symptoms, their timeline, and any treatments that have failed. A pattern of antibiotic-resistant infection is one of the strongest clinical clues pointing toward a fungal rather than bacterial cause.

The unfortunate reality is that no blood test, no at-home kit, and no routine screening exam can definitively detect mold in a breast implant while it is still in place. The best currently available approach is a combination of clinical suspicion, targeted imaging, and laboratory analysis of aspirated fluid or explanted tissue using methods specifically designed to find fungi. As PCR-based testing becomes more widely available and more surgeons adopt comprehensive culture protocols, the detection gap should narrow. For now, the single most important factor is awareness: knowing that mold is a real possibility, that standard tests can miss it, and that you may need to specifically ask for the right tests to be ordered.

The Role of Biofilm in Hiding Mold From Detection

One reason mold in breast implants is so hard to find is biofilm. When microorganisms attach to the surface of an implant or the inner lining of the capsule, they do not float freely in a way that makes them easy to detect in aspirated fluid. Instead, they form structured communities encased in a protective matrix of sugars and proteins. This biofilm shields the organisms from the immune system, from antibiotics and antifungals, and from the sampling methods used in routine diagnostics.

A fungal biofilm on an implant capsule may release very few free-floating cells into the surrounding fluid. That means a fine-needle aspiration of peri-implant fluid might come back negative for fungi even when a thriving biofilm sits millimeters away on the capsule wall. This is part of why PCR testing of capsular tissue is more sensitive than fluid culture for detecting fungal presence.⁷ The DNA is locked in the tissue, not floating in the fluid. And it is part of why some patients who feel unwell with implants in place receive clean culture results and are told nothing is wrong, only to have mold identified when the capsule is finally removed and analyzed properly.

Filamentous molds are especially adept at this. Their branching hyphae weave into the collagen fibers of the capsule, creating a physical integration between the organism and the host tissue that is nearly impossible to detect without removing and testing the tissue itself.¹ This is not a failure of modern medicine so much as a reflection of the biology involved. Biofilm-associated infections on implanted devices, whether breast implants, joint replacements, or heart valves, are among the hardest infections in medicine to diagnose and treat. The device itself is often the problem, and removal is often the solution.

1
PubMed Central. Inflammatory Pathology and Mechanisms of Filamentous Fungal Infection in Breast Implants: A Commentary
2
PLOS ONE. A Rare Fungal Species, Quambalaria cyanescens, Isolated from a Patient after Augmentation Mammoplasty – Environmental Contaminant or Pathogen?
3
British Journal of Plastic Surgery. Candida colonisation within a silicone tissue expander
4
PubMed Central. A surprising complication of breast augmentation surgery
5
PubMed Central. Incidence of benign and malignant peri‐implant fluid collections and masses on magnetic resonance imaging in women with silicone implants
6
PubMed Central. Breast Implant Illness: A Biofilm Hypothesis
7
PubMed. PCR Capsule Testing: What Standard Pathology Misses
8
Annals of Plastic Surgery. Aspergillus fumigatus Spores Are Not Able to Penetrate Silicone Breast Implant Shells